Cargando…
Hematological malignancies in systemic lupus erythematosus: clinical characteristics, risk factors, and prognosis—a case-control study
BACKGROUND: Systemic lupus erythematosus (SLE) is a chronic and complex multi-system autoimmune disorder. Higher risks of hematological malignancies (HM) were observed in SLE patients, which was associated with higher mortality. The mechanism and risk factors of HM oncogenesis in SLE patients are st...
Autores principales: | Zhang, Yuqi, Li, Wei, Zhang, Panpan, Guo, Jinyan, Sun, Jinlei, Lu, Jiameng, Liu, Shengyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722144/ https://www.ncbi.nlm.nih.gov/pubmed/34980230 http://dx.doi.org/10.1186/s13075-021-02692-8 |
Ejemplares similares
-
Nonlymphoma hematological malignancies in systemic lupus erythematosus
por: Lu, M, et al.
Publicado: (2012) -
Alterations in the human oral microbiota in systemic lupus erythematosus
por: Guo, Jinyan, et al.
Publicado: (2023) -
Hematological Disorders in Patients with Systemic Lupus Erythematosus
por: Bashal, Fozya
Publicado: (2013) -
The relationship between cancer and medication exposure in patients with systemic lupus erythematosus: a nested case-control study
por: Guo, Jinyan, et al.
Publicado: (2020) -
Long-term immunosuppression and multiple transplants predispose systemic lupus erythematosus patients with cytopenias to hematologic malignancies
por: Lanjewar, Sonali, et al.
Publicado: (2021)